In the meta-analysis, SGLT2 inhibitors significantly reduced major adverse cardiovascular events (MACE), hospitalization for heart failure (HF) plus CV death, and progression of CKD by 11%, 23% and 33%, respectively, compared to placebo
Moreover, in the ileum and colon, active GLP-1 contents were actually 2- and 1.5-fold, respectively, higher than the stomach active GLP-1 content (Fig
Vitamin C helps regenerate glutathione after its been used up fighting free radicals in your body
S., Disraeli, P., & McGregor, T
Our main concern was whether the outcome variables would differ between periods when patients received an evening dose, and when they received a morning dose